120 related articles for article (PubMed ID: 31526128)
1. From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor.
Saliba J; Belsky N; Patel A; Thomas K; Carroll WL; Pierro J
Pediatr Dev Pathol; 2020; 23(2):167-171. PubMed ID: 31526128
[TBL] [Abstract][Full Text] [Related]
2. Repeat nephron-sparing surgery for children with bilateral Wilms tumor.
Kieran K; Williams MA; McGregor LM; Dome JS; Krasin MJ; Davidoff AM
J Pediatr Surg; 2014 Jan; 49(1):149-53. PubMed ID: 24439600
[TBL] [Abstract][Full Text] [Related]
3. Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor.
Murphy AJ; Chen X; Pinto EM; Williams JS; Clay MR; Pounds SB; Cao X; Shi L; Lin T; Neale G; Morton CL; Woolard MA; Mulder HL; Gil HJ; Rehg JE; Billups CA; Harlow ML; Dome JS; Houghton PJ; Easton J; Zhang J; George RE; Zambetti GP; Davidoff AM
Nat Commun; 2019 Dec; 10(1):5806. PubMed ID: 31862972
[TBL] [Abstract][Full Text] [Related]
4. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
5. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of effect of preoperative chemotherapy on Wilms' tumor histopathology.
Taskinen S; Lohi J; Koskenvuo M; Taskinen M
J Pediatr Surg; 2018 Aug; 53(8):1611-1614. PubMed ID: 29074135
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
[TBL] [Abstract][Full Text] [Related]
8. Effect of Wilms tumor histology on response to neoadjuvant chemotherapy.
Taskinen S; Leskinen O; Lohi J; Koskenvuo M; Taskinen M
J Pediatr Surg; 2019 Apr; 54(4):771-774. PubMed ID: 29887169
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor and horseshoe kidneys: a case report and review of the literature.
Huang EY; Mascarenhas L; Mahour GH
J Pediatr Surg; 2004 Feb; 39(2):207-12. PubMed ID: 14966742
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
11. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
[TBL] [Abstract][Full Text] [Related]
12. Pathological Features of the Unilateral Favorable Histology Nephroblastoma with Relapse.
Fukuzawa H; Aoba T; Yoshida M; Iwafuchi H; Koike J; Kitagawa H; Urushihara N; Yokoi A; Maeda K
Fetal Pediatr Pathol; 2015; 34(6):383-90. PubMed ID: 26470944
[TBL] [Abstract][Full Text] [Related]
13. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
[TBL] [Abstract][Full Text] [Related]
14. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
[No Abstract] [Full Text] [Related]
15. Juxtarenal Wilms tumor in an adolescent.
Gordetsky J; Katzman P; Rashid H
Urology; 2012 Oct; 80(4):922-4. PubMed ID: 22901816
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Mavinkurve-Groothuis AM; van den Heuvel-Eibrink MM; Tytgat GA; van Tinteren H; Vujanic G; Pritchard-Jones KL; Howell L; Graf N; Bergeron C; Acha T; Catania S; Spreafico F
Pediatr Blood Cancer; 2015 Apr; 62(4):598-602. PubMed ID: 25546733
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour.
Maschietto M; Piccoli FS; Costa CM; Camargo LP; Neves JI; Grundy PE; Brentani H; Soares FA; Camargo Bd; Carraro DM
Eur J Cancer; 2011 Dec; 47(18):2715-22. PubMed ID: 21703850
[TBL] [Abstract][Full Text] [Related]
18. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of the WT-2009 chemotherapy protocol in treatment of Wilms' tumor in children].
Guo X; Lin C; Gao J; Zhou CY; Li Q; Zhu YP
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):262-5. PubMed ID: 25815497
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]